-
앱클론(주) 서울특별시 구로구 디지털로 285
(구로동, 에이스트윈타워1차) 14층
T. 02-2109-1294
F. 02-2109-1296
E. abclon@abclon.com
Based on this innovative new drug development platform and experience in developing antibody therapy,
AbClon will lead the development of intractable therapy, giving hope to patients and their families.
번호 | 제목 | 날짜 | 조회 |
24 |
Biosynergy Antibody Biosynergy AntibodyBiosynergy AntibodyBiosynergy AntibodyBiosynergy AntibodyBiosynergy Antibody
|
2021-01-02 | 69 |
24 |
Biosynergy Antibody
|
2021-01-02 | 69 |
24 |
Biosynergy Antibody
|
2021-01-02 | 69 |
24 |
Biosynergy Antibody |
2021-01-02 | 69 |
24 |
Biosynergy Antibody |
2021-01-02 | 69 |
24 |
Biosynergy Antibody |
2021-01-02 | 69 |
24 |
Biosynergy Antibody |
2021-01-02 | 69 |
24 |
Biosynergy Antibody |
2021-01-02 | 69 |
24 |
Biosynergy Antibody |
2021-01-02 | 69 |